Professor, Laboratory Medicine, University of Washington School of Medicine
Pathology
Dr. Petrie M. Rainey, MD
|
|
Give Review
Petrie M. Rainey, MD is an expert in the field of Pathology. Petrie Rainey is a published doctor and has 86 publications published. The lastest was: 'Thyroid function in lead smelter workers: absence of subacute or cumulative effects with moderate lead burdens.'
Publications
- Point-of-Care Testing: Is Faster Better?
- Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individuals.
- Interactions between Alcohol and the HIV Entry Inhibitor Maraviroc.
- Interactions Between Alcohol and the Antiretroviral Medications Ritonavir or Efavirenz.
- Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir.
- Ketoacidosis with unexpected serum isopropyl alcohol.
- Use of the BD vacutainer rapid serum tube reduces false-positive results for selected beckman coulter Unicel DxI immunoassays.
- Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients.
- A rapid and simple high-performance liquid chromatography assay for the leflunomide metabolite, teriflunomide (A77 1726), in renal transplant recipients.
- Too much of a good thing: a woman with hypertension and hypokalemia.
- Reducing routine ionized calcium measurement.
- Two cases with unusual vancomycin measurements.
- Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry.
- Rapid quantitative method using spin columns to measure porphobilinogen in urine.
- Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.
- Laboratory turnaround time does not affect emergency department length of stay.
- Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.
- Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir.
- Automatic reporting of estimated glomerular filtration rate--jumping the gun?
- Specific detection of anabasine, nicotine, and nicotine metabolites in urine by liquid chromatography-tandem mass spectrometry.
- Fisher ratio method applied to third-order separation data to identify significant chemical components of metabolite extracts.
- Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine.
- Phenytoin overview--metabolite interference in some immunoassays could be clinically important.
- Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir.
- Repeat examination of synovial fluid for crystals: is it useful?
- The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.
- HIV drug interactions: the good, the bad, and the other.
- The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects.
- On the active site topography of isoleucyl transfer ribonucleic acid synthetase of Escherichia coli B.
- Metabolism and mechanism of action of formycin B in Leishmania.
- Digibind and free digoxin.
- Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.
- Sensitivity of erythrocyte protoporphyrin as a screening test for lead poisoning.
- Modified directly observed therapy (MDOT) for injection drug users with HIV disease.
- DuPont/HFM Forum on carpet in health care facilities. Roundtable discussion.
- Management of a Sabiá virus-infected patients in a US hospital.
- Thyroid function in lead smelter workers: absence of subacute or cumulative effects with moderate lead burdens.
- Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).
- Outcomes assessment for point-of-care testing.
- A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate.
- The effect of fluconazole on the clinical pharmacokinetics of methadone.
- Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime).
- Strategies for physician education in therapeutic drug monitoring.
- Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis.
- Metabolite and matrix interference in phenytoin immunoassays.
- Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii.
- Rapid high-performance liquid chromatographic assay for atovaquone.
- Diagnosis and misdiagnosis of poisoning with the cyanide precursor acetonitrile: nail polish remover or nail glue remover?
- Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisal.
- Leishmania pifanoi: kinetics of messenger RNA expression during amastigote to promastigote transformation in vitro.
- Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy.
- Solid-phase extraction combined with radioimmunoassay for measurement of zalcitabine (2',3'-dideoxycytidine) in plasma and serum.
- Alcohol testing in the clinical laboratory: alternative remedies.
- Antileishmanial activity of sodium stibogluconate fractions.
- Relation between serum and whole-blood ethanol concentrations.
- No detectable systemic absorption of topically administered ophthalmic tobramycin.
- Erroneous results with diluted Emit reagents.
- Screening for lead poisoning in an urban pediatric clinic using samples obtained by fingerstick.
- Comparability of capillary and venous blood samples for lead screening.
- The PGPA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux.
- Monitoring blood glucose meters.
- Identification of patients for pharmacologic review by computer analysis of clinical laboratory drug concentration data.
- Testing reckless drivers for substance abuse.
- Screening for lead poisoning by fingerstick in suburban pediatric practices.
- Pyrimethamine analysis by enzyme inhibition and HPLC assays.
- In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.
- In vitro tryptophan catabolism by Leishmania donovani donovani promastigotes.
- Clinical problem-solving: the landlady confirms the diagnosis.
- Fatal iatrogenic salicylate intoxication in a long-term user of enteric-coated aspirin.
- Effects of digoxin immune Fab (ovine) on digoxin immunoassays.
- A carbon-13 nuclear magnetic resonance analysis of the products of glucose metabolism in Leishmania pifanoi amastigotes and promastigotes.
- Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?
- Biochemical and molecular characterization of Leishmania pifanoi amastigotes in continuous axenic culture.
- Effect of opioid dependence pharmacotherapies on zidovudine disposition.
- Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention.
- Interaction of methadone with didanosine and stavudine.
- Performance characteristics of three serum iron and total iron-binding capacity methods in acute iron overdose.
- Total iron binding capacity in iron overdose.
- The clinical pharmacokinetics of pyrazinamide in HIV-infected persons with tuberculosis.
- Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.
- Effect of cocaine use on methadone pharmacokinetics in humans.
- Effect of cocaine use on buprenorphine pharmacokinetics in humans.
- Lack of clinically significant drug interactions between nevirapine and buprenorphine.
- Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir.
- The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis.
Schools
University of North Carolina At Chapel Hill
University Calif
Doctors Specialties
- Clinical Pathology
- Pathology
Accepted Insurances
Education
-
UCSF
Helpful Reviews
Similar Doctors
|
|
Dr. James S. Fine, MD |
|
|
Dr. Donald R. Howard, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael L. Astion, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda D. Burkhardt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colin C. Pritchard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald C. Finkel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katie E. Wilkinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Sherer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Denise A. Wells, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Chou, MD |